Format

Send to

Choose Destination
J Mol Endocrinol. 2017 Jul;59(1):49-59. doi: 10.1530/JME-17-0066.

A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses.

Author information

1
Department of Nutrition and Food ScienceTexas A&M University, College Station, USA.
2
Department of Endocrinologythe Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
3
Department of Cardiologythe Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
4
Vascular Biology CenterDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, USA cdwu@tamu.edu YHUO@augusta.edu.
5
Drug Discovery CenterKey Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, China.
6
Department of Nutrition and Food ScienceTexas A&M University, College Station, USA cdwu@tamu.edu YHUO@augusta.edu.

Abstract

Metformin improves obesity-associated metabolic dysregulation, but has controversial effects on adipose tissue inflammation. The objective of the study is to examine the direct effect of metformin on adipocyte inflammatory responses and elucidate the underlying mechanisms. Adipocytes were differentiated from 3T3-L1 cells and treated with metformin at various doses and for different time periods. The treated cells were examined for the proinflammatory responses, as well as the phosphorylation states of AMPK and the expression of PFKFB3/iPFK2. In addition, PFKFB3/iPFK2-knockdown adipocytes were treated with metformin and examined for changes in the proinflammatory responses. The following results were obtained from the study. Treatment of adipocytes with metformin decreased the effects of lipopolysaccharide on inducing the phosphorylation states of JNK p46 and on increasing the mRNA levels of IL-1β and TNFα. In addition, treatment with metformin increased the expression of PFKFB3/iPFK2, but failed to significantly alter the phosphorylation states of AMPK. In PFKFB3/iPFK2-knockdown adipocytes, treatment with metformin did not suppress the proinflammatory responses as did it in control adipocytes. In conclusion, metformin has a direct effect on suppressing adipocyte proinflammatory responses in an AMPK-independent manner. Also, metformin increases adipocyte expression of PFKFB3/iPFK2, which is involved in the anti-inflammatory effect of metformin.

KEYWORDS:

adipocyte; inducible 6-phosphofructo-2-kinase; inflammatory responses; metformin; obesity

PMID:
28559290
PMCID:
PMC5512603
DOI:
10.1530/JME-17-0066
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center